Louisiana's ABA denial rate holds below the non-behavioral-health rate in all seven quarters that exist, but the series starts in Q4 2023, not 2019, and the 7.2x payer spread is a small-denominator artifact sitting on top of a real ~2x one
The question
Verbatim: "Does the Louisiana ABA denial rate hold across the full Act 233 quarterly series back to calendar 2019, and does the 7.2x per-MCO spread persist or was Q2 2025 an outlier?"
Context: [[2026-10-17-state-medicaid-behavioral-health-denial-rates-by-category]] read one quarter (Q2 2025) of the Healthy Louisiana Claims Report and found Applied Behavior Analysis (ABA) denied at 9.31% against 16.79% for non-behavioral-health categories, with a 7.2x spread across six managed care organizations (MCOs). This brief reads the whole series. Acronyms: ABA = Applied Behavior Analysis; BH = behavioral health; MCO = managed care organization; LDH = Louisiana Department of Health. MCO codes as printed: ABH = Aetna Better Health, ACLA = AmeriHealth Caritas Louisiana, HBL = Healthy Blue, HUM/HHH = Humana Healthy Horizons, LHCC = Louisiana Healthcare Connections, UHC = UnitedHealthcare.
What we already know (from the vault)
- The one-quarter headline. [[2026-10-17-state-medicaid-behavioral-health-denial-rates-by-category]]: Q2 2025, ABA 10,241 denied of 109,991 adjudicated lines = 9.31%; all three BH rows 14.18%; all non-BH outpatient and professional rows 16.79%; per-MCO ABA rates 11.0 / 5.0 / 11.4 / 34.7 / 8.6 / 35.9%, a 7.2x spread. I re-derived every one of these from the PDF and they reproduce exactly.
- That brief assumed a six-year ABA series. It says Louisiana has published the by-category table "since roughly calendar 2019." That is half right, and the wrong half is the ABA half (below).
- It flagged the spread as possibly a reporting artifact because the report is MCO-self-reported with gaps, and used the spread as the basis for a payer-variance product thesis.
- Before Louisiana there was no ABA rate anywhere. [[2026-10-04-behavioral-health-claim-denial-rate-primary-sources]] found only Virginia's commercial fully-insured figures and a clean null on ABA.
What the web says
All figures below are from 26 LDH report PDFs that I downloaded from ldh.la.gov and parsed (pdftotext -layout, then scripted extraction; the Q2 2025 parse reconciles to the parent brief to the claim). Quarters read: every quarter from 2018 Q2 through 2025 Q2 (29 quarters), no sampling. 2018 Q2 to 2023 Q3 come from the rolling four-quarter tables in 19 Act 710-format reports; 2023 Q4 to 2025 Q2 come from Table 1.8 of the seven Act 233-format reports. Statewide aggregates are my derivation from published counts; the reports print per-MCO percentages only.
- PRIMARY. The premise of the question is wrong in one important way: there is no ABA series back to 2019. ABA is a published line for exactly seven quarters, 2023 Q4 through 2025 Q2. The Q4 2023 report states "This report is the first quarterly report on the new Act 233 requirements." The 19 earlier quarterly reports (Act 710 of 2018, prepared by Burns & Associates / HMA) carry two behavioral-health lines only, "Mental/Behavioral Health, Rehab" and "Mental/Behavioral Health, Other than Rehab," and the string "Applied Behavior" appears zero times in any of them. Those reports do not say which category ABA claims fell into. Confidence: high.
- PRIMARY. ABA below non-BH holds in 7 of 7 quarters, by a wide and stable margin. Gross denial rate = total denied / adjudicated, line level:
| Quarter | ABA denied / adjudicated | ABA | BH - Residential | All Other Specialized BH | All BH | Non-BH | ABA minus non-BH |
|---|---|---|---|---|---|---|---|
| 2023 Q4 | 7,089 / 89,085 | 7.96% | 7.56% | 16.14% | 14.76% | 14.84% | -6.9 pts |
| 2024 Q1 | 7,864 / 88,589 | 8.88% | 9.49% | 16.59% | 15.37% | 17.21% | -8.3 pts |
| 2024 Q2 | 6,627 / 102,855 | 6.44% | 9.75% | 17.08% | 15.59% | 17.20% | -10.8 pts |
| 2024 Q3 | 6,892 / 98,583 | 6.99% | 10.73% | 18.07% | 16.59% | 16.40% | -9.4 pts |
| 2024 Q4 | 9,136 / 102,097 | 8.95% | 10.92% | 15.62% | 14.72% | 16.06% | -7.1 pts |
| 2025 Q1 | 9,174 / 96,479 | 9.51% | 10.57% | 14.72% | 13.87% | 16.47% | -7.0 pts |
| 2025 Q2 | 10,241 / 109,991 | 9.31% | 9.12% | 15.38% | 14.18% | 16.79% | -7.5 pts |
ABA ranges 6.4% to 9.5%; non-BH ranges 14.8% to 17.2%. Net of claims denied as exact duplicates (a row the report also publishes), ABA is 4.9% to 7.9% and the ordering is unchanged. Q2 2025 was not an outlier on the level; it is the second-highest ABA quarter of seven. The drift is mildly upward: the last three quarters (8.95 / 9.51 / 9.31) sit above the first four (7.96 / 8.88 / 6.44 / 6.99). Confidence: high on arithmetic, medium on interpretation for the reasons under methodology flags.
- PRIMARY. The broader "behavioral health is denied less" claim is much weaker than the ABA claim. All-BH sits below non-BH in 6 of 7 Act 233 quarters, but by 0.1 to 2.6 points, and it reverses in 2024 Q3 (16.59% vs 16.40%). "All Other Specialized Behavioral Health," which is about 80% of BH line volume, runs 14.7% to 18.1% and is above the non-BH rate in two of seven quarters (2023 Q4, 2024 Q3) and within 1.5 points of it in two more. The below-average result is carried by ABA and BH - Residential.
- PRIMARY. In the older Act 710 series, behavioral health was denied slightly MORE than non-behavioral-health in 20 of 22 quarters. Denial rate there = denied / (paid + denied), all MCOs combined. Comparator is my basket of the non-BH outpatient and professional categories that print in every report (outpatient hospital, home health, primary care, pediatrics, OB-GYN, therapists, non-emergency transport, medical equipment, all other professional; inpatient, dental, pharmacy and "other institutional" excluded).
| Quarter | Mental/Behavioral Rehab | Mental/Behavioral Other | BH combined | Non-BH basket |
|---|---|---|---|---|
| 2018 Q2 | 10.38% | 14.01% | 11.75% | 12.82% |
| 2018 Q3 | 12.45% | 13.75% | 12.99% | 13.62% |
| 2018 Q4 | 14.73% | 16.33% | 15.52% | 14.19% |
| 2019 Q1 | 16.02% | 14.91% | 15.37% | 15.04% |
| 2019 Q2 | 21.87% | 16.70% | 18.62% | 14.36% |
| 2019 Q3 | 14.76% | 21.38% | 19.34% | 14.28% |
| 2019 Q4 | 14.62% | 17.37% | 16.52% | 12.22% |
| 2020 Q1 | 13.11% | 16.17% | 15.27% | 12.67% |
| 2020 Q2 | 11.48% | 15.77% | 14.68% | 13.83% |
| 2020 Q3 | 9.74% | 16.06% | 14.62% | 13.00% |
| 2020 Q4 | 10.60% | 17.42% | 15.95% | 12.77% |
| 2021 Q1 | 13.36% | 22.20% | 20.31% | 14.23% |
| 2021 Q2 | 11.46% | 14.58% | 13.98% | 13.95% |
| 2021 Q3 | 20.29% | 19.01% | 19.27% | 13.99% |
| 2021 Q4 | 9.76% | 16.99% | 15.67% | 13.40% |
| 2022 Q1 | 9.89% | 14.54% | 13.71% | 13.52% |
| 2022 Q2 | 12.59% | 15.84% | 15.24% | 12.82% |
| 2022 Q3 | 11.38% | 15.85% | 15.10% | 13.42% |
| 2022 Q4 | 12.03% | 13.70% | 13.43% | 12.94% |
| 2023 Q1 | 20.96% | 17.04% | 17.67% | 16.84% |
| 2023 Q2 | 19.79% | 15.13% | 15.86% | 15.75% |
| 2023 Q3 | 20.54% | 15.86% | 16.60% | 15.38% |
The first Act 710 report says so in words: "The claims denial rates for behavioral health services are slightly higher than those found for most acute care services." BH combined ran 11.8% to 20.3%, the non-BH basket 12.2% to 16.8%. The BH lines are also spikier: Rehab jumped to roughly 20-22% in 2019 Q2, 2021 Q3 and all of 2023 Q1-Q3, each time without a matching move in non-BH. The two eras are not one continuous series (different categories, different formula, different non-BH basket), so the apparent flip from "BH slightly higher" to "BH slightly lower" at 2023 Q4 cannot be read as a real change. Confidence: high on the figures, low on any cross-era comparison.
- PRIMARY. The 7.2x spread is not persistent as a number, and the number is not meaningful. The all-six-MCO spread by quarter is 38x, 13x, 4.1x, 13x, 182x, 14x, 7.2x. It is set almost entirely by three MCOs that adjudicate almost no ABA:
| Quarter | ABH | ACLA | HBL | HUM | LHCC | UHC | Min-max, all six | Spread | Spread, three MCOs with 10k+ lines |
|---|---|---|---|---|---|---|---|---|---|
| 2023 Q4 | 0.6% (165) | 5.6% (12,932) | 7.4% (13,781) | 23.1% (143) | 8.6% (61,254) | 4.7% (810) | ABH - HUM | 38x | 1.5x |
| 2024 Q1 | 2.7% (112) | 6.0% (11,435) | 11.4% (14,509) | 33.8% (130) | 8.8% (60,901) | 6.8% (1,502) | ABH - HUM | 13x | 1.9x |
| 2024 Q2 | 21.3% (422) | 5.2% (15,530) | 6.7% (15,907) | 8.9% (79) | 6.5% (69,779) | 8.5% (1,138) | ACLA - ABH | 4.1x | 1.3x |
| 2024 Q3 | 10.3% (416) | 3.8% (13,982) | 7.2% (15,552) | 48.3% (29) | 7.6% (67,679) | 3.6% (925) | UHC - HUM | 13x | 2.0x |
| 2024 Q4 | 0.3% (385) | 4.7% (14,318) | 6.7% (16,818) | 47.2% (53) | 10.2% (69,174) | 16.5% (1,349) | ABH - HUM | 182x | 2.2x |
| 2025 Q1 | 7.2% (278) | 2.8% (13,834) | 9.0% (16,126) | 39.6% (96) | 10.9% (64,593) | 16.5% (1,552) | ACLA - HUM | 14x | 3.9x |
| 2025 Q2 | 11.0% (454) | 5.0% (15,843) | 11.4% (20,183) | 34.7% (838) | 8.6% (70,564) | 35.9% (2,109) | ACLA - UHC | 7.2x | 2.3x |
Gross rate, adjudicated ABA lines in parentheses. Humana's rate rests on 29 to 838 lines, Aetna's on 112 to 454, UnitedHealthcare's on 810 to 2,109. ACLA, HBL and LHCC adjudicate 97% to 99% of all ABA lines every quarter, and LHCC alone 64% to 69%. Among those three the spread is 1.3x to 3.9x, median about 2x. Confidence: high.
- PRIMARY. Inside the noise there are two persistent payer signals. ACLA is the lowest of the three high-volume MCOs in all seven quarters (2.8% to 6.0%), roughly half of HBL and LHCC throughout. Humana is the highest of six in five of seven quarters (23% to 48%), on tiny counts. A third is a trend rather than a level: UnitedHealthcare goes 4.7 / 6.8 / 8.5 / 3.6 / 16.5 / 16.5 / 35.9%, so the Q2 2025 maximum that produced "7.2x" is the end of a three-quarter climb at one small-volume payer, not a standing feature.
- Methodology and category changes, by quarter (the deliverable asked for these explicitly):
- 2023 Q4: series break. Act 710 format (Burns & Associates / HMA, two BH categories, rate = denied / (paid + denied), graphical exhibits with numeric appendices) is replaced by the Act 233 format (LDH-prepared, three BH categories including ABA, 21 outpatient and professional categories, rate = denied / adjudicated, MCO "Report 152"). The non-BH basket also changes: Act 233 adds adult dental, ambulance, radiology, personal care, pediatric day health care, hospice and rehab.
- 2023 Q4 through 2024 Q4 were published retroactively in a batch, dated June to August 2025; 2025 Q1 and Q2 are both dated February 2026. These are not contemporaneous filings.
- 2024 Q1: the printed "% Denied" is net of duplicate denials ((total denied - denied as duplicate) / adjudicated; verified on ABA for four MCOs). In the other six quarters the printed percentage is gross. Anyone comparing printed percentages across quarters will see a false dip in 2024 Q1. My tables use gross throughout.
- Source errors found in Table 1.8. 2024 Q4: UnitedHealthcare outpatient-hospital denied count printed "149.839" (I read it as 149,839, which matches the printed 11.9%); Humana adult dental shows 6,021 denied of 3,523 adjudicated. 2023 Q4: three printed percentages do not reconcile to their counts (Home Health, Outpatient Hospital HBL, BH - Residential HBL). 2024 Q1: Humana Primary Care - Pediatrics prints 82.2% denied on 170,794 lines against 5,000 to 10,000 lines in every other quarter. None touch the ABA row, but they move the non-BH comparator by up to a point and show the validation pass is light.
- Roster change. Five MCOs through 2022; Humana joins January 2023, so six from 2023 Q1.
- LDH's own documents disagree on the Act's year. The Q4 2023 report says Act 233 passed "During the 2023 Regular Legislative Session"; the Q2 2025 cover says "Act 233 of the 2022 Regular Legislative Session." Unresolved here.
- Standing caveats, all quarters: MCO self-reported ("MCEs self-report all data to LDH"; missing data submitted "as a blank or zero"); status is the last adjudication in the period, not final; line level, not header level.
Convergences and contradictions
- Converges with the parent brief on the ABA level, and upgrades it from n=1 to n=7. 9.31% was representative, not lucky. The range is 6.4% to 9.5% and the gap to non-BH never closes to less than 6.9 points.
- Contradicts the parent brief on series length and on the spread. There is no six-year ABA series, and the "7.2x spread, larger than any BH-versus-medical gap" framing does not survive: it is a ratio whose numerator or denominator is a payer with a few hundred claims. The defensible version is roughly 2x among the payers that carry the volume.
- Contradicts the parent brief's broader sentence that "on the Medicaid line, behavioral health is denied less." In Louisiana that is true for ABA and residential, marginal and unstable for all-BH in the Act 233 era, and the opposite in 20 of 22 Act 710 quarters. The ABA finding should be quoted as an ABA finding.
Synthesis for RDCO
The finding that was worth protecting holds. ABA is denied at 6% to 10% on Louisiana Medicaid managed care in every quarter anyone has published, against 15% to 17% for the non-behavioral-health categories in the same table, across roughly 688,000 adjudicated ABA lines. That is enough to quote, with three qualifiers that should travel with it every time: seven quarters and one state, MCO-self-reported, and last-adjudication-in-period rather than final. The vendor "15-30% ABA initial denial" claim is still contradicted. What cannot be said is that this is a six-year result. ABA was not a reported line before Q4 2023, and the entire seven-quarter series was first published between June 2025 and February 2026.
The payer-variance thesis from the parent brief needs to be rebuilt on a smaller number. "7.2x" should be retired; it is one quarter's ratio between a payer with 15,843 ABA lines and one with 2,109, and the same calculation gives 182x one quarter and 4.1x another. What is real is narrower and probably more useful. First, among the three MCOs that process 97-99% of Louisiana ABA, the best payer runs about half the denial rate of the other two in every one of seven quarters. A persistent 2x under one state's rules is a payer-rules effect a provider cannot see from inside one practice, which is the original product argument at honest scale. Second, the volume distribution is itself a finding: one MCO carries two-thirds of the state's ABA lines, and three large MCOs (including UnitedHealthcare, which adjudicates over a million outpatient-hospital lines a quarter) report almost none. Either ABA members and providers are concentrated to a degree enrollment shares would not predict, or the MCOs classify ABA claims into different rows. The report cannot distinguish these, and the second reading would mean the per-MCO ABA rates are not measuring the same thing. That is my inference, not a published statement.
For the family venture conversation this changes the wording, not the direction. The question to a multi-site ABA operator stays "what is your denial rate by payer, and how far is your worst from your best," but the public benchmark to hold against it is "about 2x between large payers, with small-book payers running 25-45% on thin volume," not 7x. The small-book observation may be the sharper wedge: Humana's ABA denial rate is 23% to 48% in six of seven quarters, and UnitedHealthcare's climbed from 4% to 36% over three quarters. For a provider, the low-volume payer is exactly where nobody on staff knows the rules, and the data is at least consistent with that. It is also consistent with noise at n=29, so it is a hypothesis to test on remittance data, not a claim to publish.
One caution on reuse. The older Act 710 series is the only long Medicaid behavioral-health denial series located, and it says BH was denied slightly more than non-BH for five years, with rehab spiking to 20%+ three separate times. Anyone citing Louisiana for "behavioral health is not denied more" is citing ABA and residential in the newer format only. The clean statement is service-specific: ABA is denied less; specialized outpatient behavioral health is denied about the same or slightly more.
Why this is in the vault
It is the n=7 check the family RCM/EOB venture needed before quoting the Louisiana ABA rate to Michael Holzum or any operator, and it replaces the 7.2x payer-spread figure in [[2026-10-17-state-medicaid-behavioral-health-denial-rates-by-category]] with a defensible ~2x among volume-carrying payers, which resizes the payer-benchmarking pitch.
Open follow-ups
- Why does one MCO (LHCC) carry 64-69% of Louisiana's adjudicated ABA lines while UnitedHealthcare, Aetna and Humana report almost none: real member and provider concentration, or inconsistent classification of ABA claims across MCO Report 152 submissions?
- Where did ABA claims sit in the Act 710 categories before Q4 2023 (Mental/Behavioral Other, Rehab, or All Other Professional), and does LDH hold MCO-level ABA data for 2018-2023 that would extend the series by records request?
- Is the UnitedHealthcare ABA climb (3.6% to 35.9% over 2024 Q3 to 2025 Q2) continued in the Q3 2025 report when it publishes, and does it coincide with a known policy or network change?
- Does any other state's by-category Medicaid report show the same pattern of ABA and residential below average while general specialized outpatient BH sits at or above it?
Related
- [[2026-10-17-state-medicaid-behavioral-health-denial-rates-by-category]]
- [[2026-10-04-behavioral-health-claim-denial-rate-primary-sources]]
- [[2026-10-01-national-rcm-eob-ai-behavioral-health-scan]]
- [[2026-10-03-behavioral-health-billing-ai-bundled-vs-standalone]]
- [[03-contacts/michael-holzum]]
Sources
Vault
06-reference/research/2026-10-17-state-medicaid-behavioral-health-denial-rates-by-category.md(parent brief; Q2 2025 figures reproduced)06-reference/research/2026-10-04-behavioral-health-claim-denial-rate-primary-sources.md(cited via the parent, not re-read)06-reference/research/2026-10-01-national-rcm-eob-ai-behavioral-health-scan.md,06-reference/research/2026-10-03-behavioral-health-billing-ai-bundled-vs-standalone.md,03-contacts/michael-holzum.md(context links carried from the parent, not re-read)
Primary, downloaded and parsed by me (all live on ldh.la.gov on 2026-11-17; file list recovered from the Wayback CDX index)
Act 233 format, Table 1.8 "Outpatient and Professional Claims Adjudicated" (ABA era):
- 2023 Q4 (June 2025): https://www.ldh.la.gov/assets/docs/LegisReports/ACT710/HealthyLouisianaClaimsReportQ42023.pdf
- 2024 Q1-Q4 (July-August 2025): https://ldh.la.gov/assets/docs/LegisReports/ACT710/2024/HLA_ClaimsQuarterlyReportQ12024.pdf (and Q22024, Q32024, Q42024 in the same folder)
- 2025 Q1 (February 2026): https://ldh.la.gov/assets/docs/LegisReports/Claims/Act233_HLA_ClaimsReportCY_Q1_2025.pdf
- 2025 Q2 (February 2026): https://ldh.la.gov/assets/docs/LegisReports/Claims/Act233_HLA_ClaimsReport_CY_Q2_2025.pdf
Act 710 format, Appendix A "Claim Denial Rates ... For All MCEs Combined, By Quarter" (19 reports, CY2019 Q1 through CY2023 Q3, each carrying a rolling four quarters, so 2018 Q2 onward), all under https://ldh.la.gov/assets/docs/LegisReports/ACT710/ unless noted:
- ACT710RS2018102019.pdf (CY2019 Q1, in the parent LegisReports folder), ACT710RS2018262020.pdf (CY2019 Q2, parent folder), Act710HealthyLouisianaClaimsReportQ3of2019FINAL.pdf, ACT710HealthyLouisianaClaimsReportCY19Q4.pdf
- Act710HealthyLouisianaClaimsReportCY2020Q1FINAL.pdf, Act710HealthyLouisianaClaimsReportCY2020Q2FINAL.pdf, Act_710_CY_2020_Q3.pdf, Act710CY2020Q4.pdf
- HealthyLouisianaClaimsQuarterlyReportQ12021-LDH_ConsolidatedReport.pdf, HealthyLouisianaClaimsQuarterlyReportQ22021-LDHConsolidatedReportFINALV3.pdf, ACT_710_of_the_2018_RS_CY_2021_Q3.pdf, HLAClaimsQuarterlyReportQ42021.pdf
- Act710Q12022FINAL.pdf, ACT710HealthyLouisianaClaimsQuarterlyReportQ2_2022.pdf, HealthyLouisianaClaimsQuarterlyReportQ32022.pdf, HealthyLouisianaClaimsQuarterlyReportQ422.pdf
- Act710ReportQ1_2023.pdf, Act710ReportQ2_2023.pdf, Healthy_Louisiana_Claims_Quarterly_Report_Q3_2023.pdf
Research budget used: QMD 0 of 5 (the parent brief supplied the vault priors). WebSearch 1 of 3. WebFetch 0 of 3; the 26 PDFs were pulled by curl and one Wayback CDX query located the filenames.
Not reached / limits: No report later than 2025 Q2 was located (filename-pattern probes for 2025 Q3 through 2026 Q3 returned 404; LDH has no stable naming, so a later report may exist under a name I did not guess). Per-MCO behavioral-health denial rates in the Act 710 era are published as charts without numeric tables in the text layer, so there is no per-MCO BH spread before 2023 Q4. The initial Act 710 report (covering CY2017) was downloaded but not parsed. The Act 710 non-BH comparator is my own basket and is not the same category set as the Act 233 non-BH rows.